VC Investor Panel: Building the Future Champions
Watch a replay of the live session here or read our top takeaways below…
Watch a replay of the live session here or read our top takeaways below…
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next generation of the venture-backed asset-centric biopharma model with the creation of Centessa Pharmaceuticals Ltd. The new company was created by acquiring, in all-share transactions, total control of 10 companies from the Medicxi portfolio. Read more at BioWorld.com
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic. Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]
Has Kiadis Found Immunotherapy’s Killer App? In Amsterdam, there has just been a glimpse of the future of cellular medicine.